Literature DB >> 8975968

The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.

T Ichida1, D H Van Thiel, T Hassanein.   

Abstract

The problem and approaches to the treatment of hepatocellular carcinoma as seen in Japan are reported. Current Japanese methods for the detection of hepatocellular carcinoma and the methods used to treat hepatocellular carcinoma are described. Included in the latter discussion is a description of the untoward effects of each treatment. Finally an alogorithm for the treatment of hepatocellular carcinoma is presented based upon the Japanese experience.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8975968

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo.

Authors:  Yanling Yang; Cheng Jin; Haimin Li; Yong He; Zhaohui Liu; Ling Bai; Kefeng Dou
Journal:  Exp Ther Med       Date:  2011-11-24       Impact factor: 2.447

2.  Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study.

Authors:  Toru Ishikawa; Michitaka Imai; Hiroteru Kamimura; Atsunori Tsuchiya; Tadayuki Togashi; Kouji Watanabe; Kei-ichi Seki; Hironobu Ohta; Toshiaki Yoshida; Tomoteru Kamimura
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.